TransAct 10 Patches 10x 40mg Flurbiprofen Patches
• Soothing
• Anti-Inflammatory
• Long-Lasting
1 of 1
Buy Now
TransAct. Each patch contains 40mg Flurbiprofen. Reg number 28/3.1/0268. Business name and address of the holder of the certificate of registration: Reckitt Benckiser Pharmaceuticals (Pty) Ltd., 8 Jet Park Road, Elandsfontein, 1601. For full prescribing information refer to the Package Insert approved by the Medicines Regulatory Authority. Customer Care Line: 0861 11 11 00. RKT-M-64447.
Product description
TransAct is an adhesive, anti-inflammatory patch that provides effective and uninterrupted relief from painful muscles and joints for 12 hours. It is applied directly to the area of your body that has been injured or is in pain. It's easy to use and comfortable to wear, so you can experience relief from pain, without any hassle.
• 12 Hour Relief
• Works on 8 common body pains
• 12 Hour Relief
• Works on 8 common body pains
Ingredients
40 mg Flurbiprofen
Usage information
TransAct is for external use only.
The affected area should be cleaned and only one patch should be applied at a time to a single site. A fresh patch is applied every 12 hours.
The backing film is removed by rubbing a corner between the fingers and the adhesive side applied to the skin. When applying TransAct to more mobile joints such as the knee or elbow, bend the joint before applying and stretch the patch around the joint
The affected area should be cleaned and only one patch should be applied at a time to a single site. A fresh patch is applied every 12 hours.
The backing film is removed by rubbing a corner between the fingers and the adhesive side applied to the skin. When applying TransAct to more mobile joints such as the knee or elbow, bend the joint before applying and stretch the patch around the joint
Safety information
Keep out of reach of children.
Safety and efficacy in children have not been established and therefore TransAct is not indicated for use in children under 12 years of age.
Insufficient safety data are available for continuous use for more than 4 weeks, therefore TransAct is not indicated for continuous use for more than 4 weeks.
TransAct should be used with caution in patients with a history of non-allergic asthma.
The safety of TransAct during pregnancy and lactation has not been established.
Safety and efficacy in children have not been established and therefore TransAct is not indicated for use in children under 12 years of age.
Insufficient safety data are available for continuous use for more than 4 weeks, therefore TransAct is not indicated for continuous use for more than 4 weeks.
TransAct should be used with caution in patients with a history of non-allergic asthma.
The safety of TransAct during pregnancy and lactation has not been established.